Literature DB >> 7734330

Juxtaposition of peroxisomes and chromosomes in mitotic hepatocytes following methyl clofenapate administration to rats.

A R Soames1, J R Foster.   

Abstract

Administration of 25 mg/kg/day methyl clofenapate to Alpk/APfSD rats for up to 4 days gave rise to hepatomegaly resulting from a combination of hepatocyte hyperplasia, mainly in the periportal region of the lobule, and centrilobular cell hypertrophy. In hepatocytes undergoing mitosis there was a redistribution of dense vesicles and some peroxisomes to the perinuclear region of the cytoplasm. With increasing length of exposure to methyl clofenapate the number of peroxisomes located in this region during mitosis increased. Chromosomes observed by electron microscopy were seen to lie in close apposition to these organelles. Immunocytochemical localization of the Phase II conjugating enzymes glutathione-S transferase B, C and E showed a dramatic reduction and redistribution of those enzymes in mitotic cells and their absence in the region of the chromosomes. These events may increase the vulnerability of DNA to damage in specific cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7734330      PMCID: PMC2001926     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  25 in total

Review 1.  Biochemical mechanisms of induction of hepatic peroxisome proliferation.

Authors:  E A Lock; A M Mitchell; C R Elcombe
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

2.  Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump.

Authors:  S R Eldridge; L F Tilbury; T L Goldsworthy; B E Butterworth
Journal:  Carcinogenesis       Date:  1990-12       Impact factor: 4.944

3.  Effect of peroxisome proliferators on intrachromosomal and interchromosomal recombination in yeast.

Authors:  R H Schiestl; J K Reddy
Journal:  Carcinogenesis       Date:  1990-01       Impact factor: 4.944

4.  The Movement of Iron-Laden Lysosomes in Rat Liver Cells During Mitosis.

Authors:  G Kent; O T Minick; E Orfei; F I Volini; F Madera-Orsini
Journal:  Am J Pathol       Date:  1965-05       Impact factor: 4.307

Review 5.  The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.

Authors:  J M Hawkins; W E Jones; F W Bonner; G G Gibson
Journal:  Drug Metab Rev       Date:  1987       Impact factor: 4.518

6.  Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators.

Authors:  B M Elliott; C R Elcombe
Journal:  Carcinogenesis       Date:  1987-09       Impact factor: 4.944

7.  Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver.

Authors:  R C Cattley; D S Marsman; J A Popp
Journal:  Carcinogenesis       Date:  1991-03       Impact factor: 4.944

Review 8.  The potential role of chemically induced hyperplasia in the carcinogenic activity of the hypolipidemic carcinogens.

Authors:  B E Butterworth; D J Loury; T Smith-Oliver; R C Cattley
Journal:  Toxicol Ind Health       Date:  1987-06       Impact factor: 2.273

9.  Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.

Authors:  J G Conway; K E Tomaszewski; M J Olson; R C Cattley; D S Marsman; J A Popp
Journal:  Carcinogenesis       Date:  1989-03       Impact factor: 4.944

10.  Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds.

Authors:  R Schulte-Hermann; I Timmermann-Trosiener; J Schuppler
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.